[Federal Register Volume 86, Number 15 (Tuesday, January 26, 2021)]
[Rules and Regulations]
[Page 7059]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-01629]



========================================================================
Rules and Regulations
                                                Federal Register
________________________________________________________________________

This section of the FEDERAL REGISTER contains regulatory documents 
having general applicability and legal effect, most of which are keyed 
to and codified in the Code of Federal Regulations, which is published 
under 50 titles pursuant to 44 U.S.C. 1510.

The Code of Federal Regulations is sold by the Superintendent of Documents. 

========================================================================


Federal Register / Vol. 86, No. 15 / Tuesday, January 26, 2021 / 
Rules and Regulations

[[Page 7059]]



DEPARTMENT OF HEALTH AND HUMAN SERVICES

42 CFR Part 51c

RIN 0906-AB25


Implementation of Executive Order on Access to Affordable Life-
Saving Medications

AGENCY: Health Resources and Services Administration (HRSA), Health and 
Human Services (HHS).

ACTION: Final rule; delay of effective date.

-----------------------------------------------------------------------

SUMMARY: In accordance with the memorandum of January 20, 2021, from 
the Assistant to the President and Chief of Staff, entitled 
``Regulatory Freeze Pending Review,'' this action temporarily delays 
for 60 days from the date of the memorandum the effective date of the 
final rule titled ``Implementation of Executive Order on Access to 
Affordable Life-saving Medications,'' published in the December 23, 
2020, Federal Register. This document announces that the effective date 
is delayed until March 22, 2021, the first business day after 60 days 
from the date of the memorandum.

DATES: The effective date of the final rule published in the December 
23, 2020, Federal Register (85 FR 83822), is delayed from January 22, 
2021, to March 22, 2021.

FOR FURTHER INFORMATION CONTACT: Jennifer Joseph, Director, Office of 
Policy and Program Development, Bureau of Primary Health Care, HRSA, 
5600 Fishers Lane, Rockville, MD 20857; by email at <a href="/cdn-cgi/l/email-protection#c0aaaaafb3a5b0a880a8b2b3a1eea7afb6"><span class="__cf_email__" data-cfemail="f09a9a9f83958098b098828391de979f86">[email protected]</span></a>; 
telephone: 301-594-4300; fax: 301-594-4997.

SUPPLEMENTARY INFORMATION: The January 20, 2021 memorandum from the 
Assistant to the President and Chief of Staff, entitled ``Regulatory 
Freeze Pending Review,'' instructed Federal agencies to delay the 
effective date of rules published in the Federal Register, but which 
have not yet taken effect, for a period of 60 days from the date of the 
memorandum. This final rule will apply to all health centers receiving 
section 330(e) grant funds that participate in the 340B Drug Pricing 
Program (340B Program), (42 U.S.C. 254b and 256b), and requires such 
entities to make insulin and injectable epinephrine available to health 
center patients identified as low-income or below the same price the 
health center paid through the 340B Program. The effective date of that 
rule, which would have been January 22, 2021, is now March 22, 2021. 
The temporary delay in the effective date of this final rule is 
necessary to give Department officials the opportunity for further 
review and consideration of new regulations, consistent with the 
memorandum of January 20, 2021, from the Assistant to the President and 
Chief of Staff, entitled ``Regulatory Freeze Pending Review.''

Norris Cochran,
Acting Secretary, Department of Health and Human Services.
[FR Doc. 2021-01629 Filed 1-21-21; 4:15 pm]
BILLING CODE 4165-15-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>